What is the current NAV of HDFC Pharma and Healthcare Fund - Growth Option?

The NAV is ₹21.725 as at 03 Sept 2026, against ₹21.673 on 02 Sept 2026 — a move of +0.24% over one day.

What are the returns of HDFC Pharma and Healthcare Fund - Growth Option?

Over 1 year it returned +26.05%. Periods with no figure are shown as —, meaning the NAV history here does not cover them.

How volatile has it been?

Annualised volatility over the last three years is 15.44% and the deepest peak-to-trough fall in that window was -15.07%. The disclosed Sharpe ratio is 1.72. The SEBI riskometer label is Very High.

What is the minimum investment?

The minimum lumpsum is ₹100. Minimum SIP: Not present in the source. Check the scheme information document before investing.

Does GFS rate or rank this scheme?

GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes. The comparisons on this page are sorts on publicly disclosed numbers — returns, expense ratio, volatility — and nothing more.

Why are some numbers blank?

A — means the figure is genuinely not in this dataset for this scheme, usually because its NAV history is shorter than the period. Across the 1648 schemes here, 91.1% have a 1-year figure, 68.3% a 3-year one and 49% a 5-year one. A blank is never filled with a zero or an estimate.

GFS » Mutual Fund » Sectoral / Thematic » HDFC Pharma and Healthcare Fund - Growth Option

HDFC

HDFC Pharma and Healthcare Fund - Growth Option

Regular Growth

₹21.725

+0.24% 1D

NAV · 03 Sept 2026 · previous ₹21.673

Sectoral / Thematic Risk: Very High 2.8y of NAV history

Min lumpsum₹100

Min SIP—

Minimum SIP: Not present in the source.

Start SIP One-time

Scorecard

↗

PerformanceNo 3Y figure

Less than three years of NAV history here, so there is no 3-year CAGR to compare.

⚠

RiskVery High

Volatility 15.44% a year; deepest fall over 3Y -15.07%.

₹

Cost83rd of 166 by expense

Expense ratio 1.11% vs a category average of 1.73% — 0.62 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 83rd of 166, cheapest first.

⏱

Track record2.8y

NAV history in this dataset covers 2.8y — full periods available: 1Y

↻

ConsistencyNo 3Y window yet

There is not yet enough published NAV here to measure a three-year rolling window.

↓

Deepest fall-14.91%

The worst peak-to-trough fall in the published series was -14.91%, from 02 Jan 2025 to 28 Feb 2025, and the old level was regained 126 days after the trough — 183 days below the peak in all.

▦

Portfolio37 securities

The fund house’s own disclosure as at 31 Jul 2026 lists 37 securities, the largest five at 32.99% of the portfolio, with 0.47% in cash.

○

What is not shownDisclosed gaps

Rating and scheme AUM are deliberately absent — open for the reason on each.

Talk to GFS for a portfolio review and goal planning →

ⓘ Compared against the 241 Sectoral/ Thematic schemes in this dataset. Factual comparisons on disclosed numbers — GFS does not rate or rank schemes.

Published NAVNAV published by the AMC, sourced from AMFI

Change+118.0%change over the window — not annualised

Low / high₹9.72 / ₹21.8526 Oct 2023 · 31 Aug 2026

Last print+0.24%2 Sep 2026 → 3 Sep 2026

Prints719published NAVs, AMFI · axis does not start at zero

Returns

NAV and returns as at 03 Sept 2026

Lumpsum · point to point

1W -0.15%

1M +2.45%

3M +12.12%

6M +23.84%

YTD +26.46%

1Y +26.05%

2Y CAGR +17.6%

3Y CAGR —

5Y CAGR —

10Y CAGR —

SIP · XIRR on monthly instalments

6M SIP +60.47%

1Y SIP +40.38%

2Y SIP +25.17%

3Y SIP —

5Y SIP —

10Y SIP —

Full history SIP +26.03%

Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68.3% have a 3-year figure, 49% a 5-year one, and 32.2% a 10-year one.

Returns vs category

This fund

+26.05%

Sectoral / Thematic avg

+7.67%

Average is the mean of every Sectoral/ Thematic scheme in this dataset that discloses the period — 218 schemes at 1Y, 128 at 3Y, 94 at 5Y. Returns beyond one year are annualised.

Top holdings

as at 31 Jul 2026 · source: AMC monthly portfolio disclosure

Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology 9.66%

Divis Laboratories Ltd.Pharmaceuticals & Biotechnology 9.14%

Max Healthcare Institute LimitedHealthcare Services 4.82%

Aster DM Quality Care LimitedHealthcare Services 4.7%

Lupin Ltd.Pharmaceuticals & Biotechnology 4.67%

Cipla Ltd.Pharmaceuticals & Biotechnology 4.64%

Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology 3.67%

Acutaas Chemicals LimitedPharmaceuticals & Biotechnology 3.58%

Anthem Biosciences LimitedPharmaceuticals & Biotechnology 3.56%

Neuland Laboratories LimitedPharmaceuticals & Biotechnology 3.4%

Top 10 51.84%Securities 37Securities total 99.53%Cash & equivalents 0.47%

The ten largest securities by weight, out of 37 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.

Risk

Volatility · annualised · 3Y

15.44%

Max drawdown · 3Y

-15.07%

Sharpe ratio

1.72

SEBI riskometer

Very High

Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).

Beta and alpha are not shown. No benchmark series in the source.

Cost

Expense ratio1.11%

Category average1.73%

Exit load1%

52W high / low₹21.85 / ₹16.364

Expense ratio 1.11% vs a category average of 1.73% — 0.62 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 83rd of 166, cheapest first.

Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.

Scheme facts

SEBI sub-category Sectoral/ Thematic

Plan / option Regular Growth

Benchmark BSE Health Care - TRI

Fund manager Nikhil Mathur

Launched 14 Sept 2023

NAV history here 2.8y

ISIN INF179KC1HO1

AMFI scheme code 152084

SEBI riskometer Very High

Exit load 1%

Lock-in None

Minimum lumpsum ₹100

Exit load, as disclosed: 1% on or before 30D · Nil after 30D

Not shown on this page, and why

Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.

Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.

Minimum SIP — Not present in the source.

Beta and alpha — No benchmark series in the source.

Compare this scheme's mandate with another →

General SIP calculator

A general SIP illustration: your monthly amount grown at the annual rate you set below, compounded monthly. The rate is your assumption — it is not this scheme’s past return, not a forecast of it, and mutual fund returns are not assured.

Monthly SIP₹10,000

Tenure10 years

Assumed annual return12%

Invested₹12,00,000

Est. gain₹11,23,391

Total value₹23,23,391

Redeem Buy / SIP